EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations

Overview of attention for article published in Virchows Archiv, July 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#41 of 1,980)
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

policy: 2 policy sources

patent: 7 patents

Citations

dimensions_citation: 188 Dimensions

Readers on

mendeley: 141 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer: Committee papers

Cited by National Institute for Health and Care Excellence on 02 Jun 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Xalkori Resubmission for First Line Advanced NSCLC - Details

Cited by Canadian Agency for Drugs and Technologies in Health on 10 Nov 2015

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.